• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACR

ACRUX LIMITED

0.00% ! 1.8¢
Market Cap $7.366M  !
Healthcare Drug Manufacturers - Specialty & Generic
Add to My Watchlist

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ACR
Ann: Licensing partnership in Saudi Arabia for Dapsone 5%, Gel 		09:21 0 96
09:21 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  96 
ACR
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		07:38 6 779
07:38 Last post  jetrodder Comments Created with Sketch.  6  Views Created with Sketch.  779 
ACR
Ann: Change in substantial holding 		25/07/25 13 3.4K
25/07/25 Last post  Furiousgeorge Comments Created with Sketch.  13  Views Created with Sketch.  3.4K 
ACR
Ann: Receipt of second advance for FY25 R&D Tax Incentive 		04/07/25 2 607
04/07/25 Last post  Socrates2 Comments Created with Sketch.  2  Views Created with Sketch.  607 
ACR
Ann: Notification of cessation of securities - ACR 		03/07/25 0 163
03/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  163 
ACR
Ann: Application for quotation of securities - ACR 		03/07/25 0 158
03/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  158 
ACR
Ann: App 3Z, Kotsanis 		24/06/25 6 2.4K
24/06/25 Last post  mwilson25 Comments Created with Sketch.  6  Views Created with Sketch.  2.4K 
ACR
Ann: App 3X, Warmbrunn 		02/06/25 0 242
02/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  242 

See All Discussions arrow Created with Sketch.

Timeline

Licensing partnership in Saudi Arabia for Dapsone 5%, Gel
31 Jul 09:01
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 09:03
 
Receipt of second advance for FY25 R&D Tax Incentive
03 Jul 09:29
 
Notification of cessation of securities - ACR
03 Jul 09:24
 
Application for quotation of securities - ACR
03 Jul 09:23
 
Change in substantial holding
30 Jun 14:58
 
View More arrow Created with Sketch.

Featured News

NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets
right-arrow Created with Sketch.
AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $7.366M
Open High Low Value Volume
2.0¢ 2.0¢ 1.7¢ $6.915K 364.6K

Buyers (Bids)

No. Vol. Price($)
1 29666 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 314326 3
View Market Depth
Last trade - 10.17am 31/07/2025 (20 minute delay) ?
ACR (ASX) Chart

Top Stories

Metal Hawk shares sink -50% as gold drill results disappoint

Spare a thought for Metal Hawk (ASX:MHK) shareholders on Thursday: the company’s latest RC gold drilling results at its Thylacine project have been dismissed as a duster by the market. Shares in MHK were down an eye-watering -50% in the first hour of trades as investors and trader...
Investors shrug as Wildcat's latest lithium drill hits fail to excite Wildcat Resources (ASX:WC8) has posted a diamond drill assay of 110m @ 1.2% lithium oxide from 193m depth above the company’s Leia Pegmatite target @ but it hasn’t been enough to cause excitement. The market had collectively shrugged heading into the second hour of...
ASX Market Open: Local bourse tipped to trade red after same on S&P500 The local market is tipped to trade red on Thursday following the S@P500 declining -0.12% overnight (though, the NASDAQ ended 30pts higher.) This comes even after the ASX200 re-entered record territory on Wednesday following a CPI read widely perceived as a signal the RBA is likely to cut in Augu...
ASX Market Close: Index rebounds as investors buoyant | July 30, 2025 The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...

Featured News

NEWS Veteran executive to help turn Trigg into leading US-based antimony producer
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Infini remobilising at Portland Creek after geo specialists line up 12 'priority' targets
right-arrow Created with Sketch.
AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.